{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:30:20Z","timestamp":1777411820932,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust N Z J Psychiatry"],"published-print":{"date-parts":[[1992,3]]},"abstract":"<jats:p>A review of the clinical efficacy of four structurally distinct antidepressant drugs is presented. Their antidepressant activity can be rationalised within current pharmacological hypotheses of drug action, despite markedly different effects on \u201cin vitro\u201d testing. Fluoxetine, a specific serotonin re-uptake inhibitor, has proven safe, effective treatment for depressive illness and may have a role to play in the treatment of obsessive-compulsive disorder and panic attacks. While it has few of the anticholinergic side effects of the tricyclic antidepressants, nausea, tremor, headache, weight loss, nervousness and sweating are side effects most frequently reported. Minaprine, a compound with weak MAO inhibiting properties and effects on serotonergic receptors, has clinical efficacy in the treatment of depression based on several comparative studies. It is claimed that minaprine lacks anticholinergic and sedative properties. Moclobemide, a specific, reversible inhibitor of MAO-A, has been extensively evaluated in depressive illness. The major advantage of this agent over other irreversible, non-specific MAO inhibitors, is the significant attenuation of the so-called \u201ccheese effect\u201d with doses of tyramine likely to be encountered in foodstuffs. Rolipram, a phosphodiesterase inhibitor, represents a new approach to antidepressant treatment. Limited clinical data suggest that the drug may be an effective antidepressant with few side effects. The place of these agents in therapy is yet to be established.<\/jats:p>","DOI":"10.3109\/00048679209068311","type":"journal-article","created":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T20:52:33Z","timestamp":1195678353000},"page":"73-81","source":"Crossref","is-referenced-by-count":12,"title":["New Pharmacological Approaches to the Management of Depression: From Theory to Clinical Practice"],"prefix":"10.1177","volume":"26","author":[{"given":"Trevor R.","family":"Norman","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona K.","family":"Judd","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham D.","family":"Burrows","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1992,3,1]]},"reference":[{"key":"bibr1-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.115.5.459"},{"key":"bibr2-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700007844"},{"key":"bibr3-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(79)90035-X"},{"key":"bibr4-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90002-5"},{"key":"bibr5-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(82)90172-1"},{"key":"bibr6-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800120041009"},{"key":"bibr7-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-09506-3_26"},{"key":"bibr8-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.29.040189.000443"},{"key":"bibr9-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90043-6"},{"key":"bibr10-00048679209068311","first-page":"12","volume":"49","author":"Leonard B E","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"bibr11-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198512000-00001"},{"key":"bibr12-00048679209068311","first-page":"18","volume":"49","author":"Burrows G D","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"bibr13-00048679209068311","volume":"153","author":"Freeman H","year":"1988","journal-title":"British Journal of Psychiatry"},{"key":"bibr14-00048679209068311","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-198910000-00010","volume":"4","author":"Silverstone T","year":"1989","journal-title":"International Clinical Psychopharmacology"},{"key":"bibr15-00048679209068311","first-page":"804","volume":"193","author":"Wong D T","year":"1975","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"bibr16-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000297274"},{"key":"bibr17-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000297304"},{"key":"bibr18-00048679209068311","first-page":"53","volume":"46","author":"Stark P","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"key":"bibr19-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1192\/S000712500029733X"},{"key":"bibr20-00048679209068311","first-page":"42","volume":"46","author":"Fisch C","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"key":"bibr21-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90287-8"},{"key":"bibr22-00048679209068311","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198632040-00002"},{"issue":"12","key":"bibr23-00048679209068311","first-page":"831","author":"Biziere K","year":"1985","journal-title":"Drugs under Experimental Clinical Research"},{"key":"bibr24-00048679209068311","unstructured":"Jouvent R, Lancrenon S, Patay M, Biziere K, Widlocher D. A controlled study of minaprine versus placebo in inhibited depressed outpatients. Abstr. International Symposium of the first European Conference \u201cRecent Advances in Psychiatric Treatment\u201d 1984 (Vienna March 26)."},{"issue":"7","key":"bibr25-00048679209068311","first-page":"435","author":"Bohacek N","year":"1987","journal-title":"Drugs under Experimental Clinical Research"},{"key":"bibr26-00048679209068311","unstructured":"Radmayr E, Biziere K, Bentel U. Comparative effects of minaprine and maprotiline in depressed inhibited patients. A double-blind study. Abstr. International Symposium at The First European Conference \u201cRecent Advances in Psychiatric Treatment\u201d 1984 (Vienna, March 26)."},{"key":"bibr27-00048679209068311","unstructured":"Mikus P, Biziere K, Bentel V. Double blind study of minaprine versus nomifensine in patients with masked depression. Abstr. International Symposium at the first Euorpean Conference \u201cRecent Advances in Psychiatric Treatment\u201d. 1984 (Vienna March 26)."},{"key":"bibr28-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.155.1.106"},{"key":"bibr29-00048679209068311","first-page":"183","volume-title":"Monoamine Oxidase: Basic and Clinical Frontiers","author":"da Prada M","year":"1981"},{"key":"bibr30-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1007\/BF00165029"},{"key":"bibr31-00048679209068311","first-page":"137","volume-title":"Monamine oxidase and disease: prospects for therapy with reversible inhibitors","author":"da Prada M","year":"1984"},{"key":"bibr32-00048679209068311","first-page":"400","volume":"248","author":"da Prada M","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"bibr33-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05357.x"},{"key":"#cr-split#-bibr34-00048679209068311.1","unstructured":"Bobon D P, Rossignol P, Lepage-Goffioul G, Adens A, Gilot P, Breulet M (1980). L'effect antidepressif du RO11-1163, inhibitor selectif de la MAO-A. In: Sizaret P (ed) Comptes Rendus 77e Congress Psychiatrie Neurolgie Francais Paris Masson 1980"},{"key":"#cr-split#-bibr34-00048679209068311.2","unstructured":"Bobon D P, Rossignol P, Lepage-Goffioul G, Adens A, Gilot P, Breulet M (1980). L'effect antidepressif du RO11-1163, inhibitor selectif de la MAO-A. In: Sizaret P"},{"key":"#cr-split#-bibr34-00048679209068311.3","unstructured":"(ed) Comptes Rendus 77e Congress Psychiatrie Neurolgie Francais Paris Masson 1980; P 1281-1286."},{"key":"bibr35-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1159\/000468556"},{"key":"bibr36-00048679209068311","first-page":"73","volume":"26","author":"Amrein R","year":"1988","journal-title":"Journal of Neural Transmission (Supplement)"},{"key":"bibr37-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.113.497.349"},{"key":"bibr38-00048679209068311","first-page":"57","volume":"26","author":"Korn A","year":"1988","journal-title":"Journal of Neural Transmission (Supplement)"},{"key":"bibr39-00048679209068311","first-page":"1108","volume":"188","author":"Horowitz D","year":"1964","journal-title":"Journal of the American Medical Association"},{"key":"bibr40-00048679209068311","first-page":"903","volume":"43","author":"Schmid-Burgk W","year":"1988","journal-title":"Current Therapeutic Research"},{"key":"bibr41-00048679209068311","first-page":"105","volume":"26","author":"Muller T","year":"1988","journal-title":"Journal of Neural Transmission (Supplement)"},{"key":"bibr42-00048679209068311","first-page":"900","volume":"12","author":"Schwabe U","year":"1976","journal-title":"Molecular Pharmacology"},{"key":"bibr43-00048679209068311","first-page":"233","volume":"35","author":"Przegalinski E","year":"1983","journal-title":"Polish Journal of Pharmacology and Pharmacy"},{"key":"bibr44-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1007\/BF01249580"},{"key":"bibr45-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017435"},{"key":"bibr46-00048679209068311","first-page":"246","volume":"96","author":"Dunner D L","year":"1988","journal-title":"Psychopharmacology"},{"key":"bibr47-00048679209068311","doi-asserted-by":"publisher","DOI":"10.1177\/026988118900300307"},{"key":"bibr48-00048679209068311","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb125126.x"}],"container-title":["Australian &amp; New Zealand Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3109\/00048679209068311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3109\/00048679209068311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:49:13Z","timestamp":1777373353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3109\/00048679209068311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["10.3109\/00048679209068311"],"URL":"https:\/\/doi.org\/10.3109\/00048679209068311","relation":{},"ISSN":["0004-8674","1440-1614"],"issn-type":[{"value":"0004-8674","type":"print"},{"value":"1440-1614","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}